Delivery Order SPE2DB20D9331-SPE2DB22FL1G9
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,671.69 firm fixed-price delivery order is for the provision of Telmisartan 40 mg tablets to support the recurring pharmaceutical supply needs of U.S. military healthcare facilities. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a firm fixed-price delivery order ceiling value of $4,541.76 and covers the supply of Telmisartan 20 mg tablets to fulfill the recurring pharmaceutical needs of military health facilities. DMS Pharmaceutical Group holds a larger indefinite-delivery contract (IDC) with the DLA under the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,678.00 to DMS Pharmaceutical Group Inc. on September 17, 2025, for the supply of Telmisartan 40 mg tablets (30-count units). This firm fixed-price delivery order, which must be completed by September 18, 2025, was issued without a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its Park Ridge location. The...
- This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,828 contract was issued by the Defense Logistics Agency (DLA) under the SPE2DB program, a $499,999,999 indefinite delivery contract that enables DLA to place orders for a wide range of pharmaceutical products to support the medical supply needs of Department of Defense (DoD) healthcare facilities worldwide. The delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,523.54 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Telmisartan 20 mg tablets (30-count units). The award, issued on October 21, 2025, with an ultimate completion date of October 22, 2025, utilizes a firm fixed-price contract structure with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania. This...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) under its SPE2DB program. The award has a ceiling value of $9,210.24 and covers the delivery of 4554944974 - Telmisartan 40 mg Tablets 30s to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $1,120.16 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Telmisartan 40 mg tablets (30-count units). The award was issued on October 27, 2025, with an ultimate completion date of October 28, 2025, under a firm fixed-price arrangement with no set-aside designation. This delivery order is issued pursuant to DMS Pharmaceutical Group's...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $405,390 to DMS Pharmaceutical Group Inc. to supply 30-count bottles of 40mg telmisartan tablets. The place of performance is DMS Pharmaceutical's facility in Park Ridge, Illinois. The period of performance is July 20-21, 2023. No set aside designation or subcontractors are indicated. This order was placed under an existing DLA medical supply vehicle to fulfill short-term needs for this...
- This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,425.24 firm fixed-price delivery order is for the supply of Micardis HCT 80-12.5 mg tablets, with a completion date of June 3, 2022. The award is not associated with a set-aside designation. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,843.20 firm fixed-price delivery order is for the supply of MICARDIS HCT 80-25 MG TABLET UD 30S, with a performance period ending on June 24, 2024. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) under the DLA's SPE2DB program, which allows the agency to issue...
- SPE2DB20D9331Indefinite Delivery Contract
- SPE2DB20D9331-SPE2DB22FL1G9Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,135.44 firm fixed-price delivery order is for the supply of Telmisartan 20 mg tablets and does not have a set-aside designation. DMS Pharmaceutical Group holds a single-award indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to support the recurring medical supply needs of military health facilities worldwide. Through this vehicle and separate prime vendor contracts, DMS Pharmaceutical Group provides both routine and critical medications to the Department of Defense healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/18/22 |